Navigation Links
Ten-Ten Duodecapolar Diagnostic Catheters

ProductsTen-Ten Duodecapolar Diagnostic Catheters
Company Irvine Biomedical Inc.
Item Ten-Ten Duodecapolar Diagnostic Catheters
Features 
  • Precision handling designed to reduce procedure times - precise torqueability and pushability catheter placement and provide long-term tip stability
  • Consistent high fidelity diagnostic electrograms - platinum iridium electrodes, gold plated connectors copper conductors produce high fidelity electrograms for easier interpretation
  • Larger mapping area - duodecapolar configuration in four curve sizes
    • Description Ten-Ten duodecapolar diagnostic mapping catheters are available in four curve sizes.
    Info Irvine Biomedical Inc.
    Customer Service: (888) IBI-9876
    Web site: http://www.ibiep.com/

    Related medicine products :

    1. Near Point Diagnostic Card Set - BC11982
    2. Ocular Koeppe Diagnostic
    3. Ocular Posner Diagnostic And Surgical Gonioprism
    4. Blu-Slit Diagnostic Light
    5. Maxi-Lite Diagnostic Penlight
    6. EPT-DX Steerable Diagnostic Catheters
    7. Inquiry Steerable Diagnostic Catheters
    8. A-Focus Steerable Diagnostic Catheters
    9. Inquiry Fixed Curve Diagnostic Catheters
    10. Inquiry HIS Diagnostic Catheters
    11. EPT-Dx Steerable Diagnostic Catheters
    Four way compression with simple contact closure
    Facial Chin and Neck Support
    Abdominal Compression for Men and Women
    Male high waisted compression girdle with CDIs Wonderfabric™
    Medicine Products:
    (Date:12/3/2008)...Aurora Health Care,s Women,s Pavilion,( http://ww...ns Salon and Spa of,New Berlin partnered for a ne...; pink hair extensions. , Throughout the mo...ld for,$15 each at the Aurora Women,s Pavilion in...and Spa in New Berlin. The profits from these brig...
    (Date:12/3/2008)...Newswire-FirstCall/ -- ThermoGenesis,Corp. (Nasda...ucts and services,that process and store adult st...ce call on Thursday, December 4, to discuss its an...he Company. , The conference call will begi... Eastern Standard Time). The call can be accessed ...
    (Date:12/3/2008)...m, an animal-free recombinant albumin product manu...man derived serum in CHO cell culture. , ...3, 2008 -- Cellastim has proven to be a robust rep...d can improve both the growth kinetics and product...ally defined media. , , ,Studies support InVitria,...
    (Date:12/3/2008)...-- In response to press reports of,parents diluti...tional expert,and a leading manufacturer of infan... formula responsibly by following the instructions... refrain from diluting baby formula with extra,wa...ra S. Levine, R.D., Ph.D.,director of the first ...
    Breaking Medicine News(10 mins):Health News:ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition 2Health News:InVitria's Cellastim Delivers Superior Results in CHO Cell Culture 2Health News:Cornell Nutritional Expert, Vermont Baby Formula Company Urge Parents Not to Dilute Formula with Extra Water 2
    ...titute of Standards and Technology (NIST) research...duce a number of complex surfaces, which vary in a...w technique is so flexible that it can be applied ...m developing better paints to exploring the bondin...
    ...long-term research a geographer from Guangdong Pro... clues to the pattern of global climate change. //...ences has opined that rising temperatures globally...eenhouse effect but in fact was a part of the cycl...
    ...appearing in the American Journal of Clinical Nutr...ur ancestors is responsible for the overweight/obe... In a study of men who chewed betel nut, it was fo...r sons and grandsons. Barbara Boucher, of the Uni...
    ... on the manner of T-cells enabling immunity and fu...us similar to AIDS will go a long way in measuring...ists during clinical trials //. Led by researcher...ter (BIDMC) and the Vaccine Research Center (VRC) ...
    Other Medicine News:Health News:New Technique For Science Experiments 2Health News:Research on AIDS vaccine a wealth of information 2Health News:Research on AIDS vaccine a wealth of information 3
    (Date:12/1/2008)...ewswire-FirstCall/ -- Vical Incorporated (Nasdaq: ...lion milestone payment from Merck & Co., Inc. ...linical trial of an investigational plasmid DNA (p...d on Vical,s DNA gene delivery technology and enco.... hTERT is the subject of separate license agreeme...
    (Date:11/28/2008)... November 28 German biotech compan...ecialized HIV monitoring and,AIDS patient follow-...es. In,the year 2008, 2.5 million patient tests h...highly affordable "CyFlow" system, supporting alre...DS. Due to introduction of the,Partec innovation,...
    (Date:11/26/2008)... 26 Children whose eyes...ntly increased risk of developing mental illness b...o Clinic study published this month in Pediatrics ...Pediatrics. , , The retrospective study exa...abismus (misaligned eyes) and compared them with r...
    (Date:11/25/2008)...improve recovery , , Audio and Web Video Re...he Mayo Clinic News Blog. Please see the bottom of...ER, Minn., Nov. 25 A Ma...s don,t think they,re having a stroke -- and as a ...ition worsens. The findings appear in the current ...
    Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Eye Divergence in Children Triples Risk of Mental Illness 2Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 1CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 2CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 3CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 4CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 5CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 6CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 7CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 8CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 9CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 10CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 11CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 12CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 13CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 14CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 15CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 16CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 17CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 18CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 19CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 20CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 21CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 22The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 1The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 2The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 3The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 4The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 5The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 6New Website Helps Doctors and Dentists Locate Disability Insurance 24714 1New Website Helps Doctors and Dentists Locate Disability Insurance 24714 2New Website Helps Doctors and Dentists Locate Disability Insurance 24714 3Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 1Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 2Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 3
    ...srael--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,Bi...d on the Tel,Aviv Stock Exchange Exchange, proceed...is is in addition to CF101, which is currently,in ... phases. This,weekend Can-Fite will present at the...d in vivo study results showing effective,anti-inf...
    ....--(BUSINESS WIRE)--Jun 14, 2007 - CombinatoRx,In...entation of,additional data related to its immuno-...39, at the European League Against,Rheumatism (EUL...13-16, 2007 in Barcelona, Spain., CRx-102 , In a p...rocyte,Inflammatory Mediators by CRx-102, a Novel ...
    Other Medicine Technology:Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 3Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 4